Login / Signup

Comparing mismatch strategies for patients being considered for ischemic stroke tenecteplase trials.

Andrew BivardXuya HuangChristopher R LeviBruce C V CampbellBharath K CheripelliChushuang ChenDheeraj KalladkaFiona C MoretonIan FordStephen M DavisGeoffrey A DonnanKeith W MuirMark W Parsons
Published in: International journal of stroke : official journal of the International Stroke Society (2019)
Target mismatch selection was more inclusive and exhibited in a larger treatment effect between tenecteplase and alteplase.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • prognostic factors
  • peritoneal dialysis
  • patient reported outcomes